The NTH Advisory Board and Steering Committee consists of world-renowned clinicians, commercialization, regulatory and ethics experts, scientists and engineers. They will ensure a rigorous proposal evaluation, support the selected solutions and guide the acceleration process of the promising new technologies. Collectively, they have more 338,000 scholarly citations for their published works, 392 patents in the neuromedical technologies space, and more than 200 nationally recognized awards.
Advisory Board
Steering Committee
| Member | Affiliation | Expertise |
|---|---|---|
| Emery Brown | MIT | Clinical, Scientist, Technology |
| Martha Morrell | CMO, Neuropace | Clinical, Business Development |
| Erika Ross | Abbott | Business Development |
| Marc Filerman | Columbia Univ. | Business Development, Technology |
| Eric J. Grigsby | Neurovations | Clinical, Patient Advocacy |
| Leigh Hochberg | Brown Univ., Center for Neurotech | Scientist, Technology |
| Holly S. Gilmer | Michigan Head & Spine Institute | Clinical |
| Sameer Seth | Baylor College of Medicine | Clinical, Neuroethics |
| Jorge Gonzalez Martinez | Director, Epilepsy & Movement Disorders, UPMC | Clinical, Technology |
| Milton Morris | NeuSpera Medical, Inc | Business Development |
| Frederick Koehn | Dixi Medical | Business Development |
| Victor Pikov | Medipace, Inc, Pasadena, CA | Business Development |
| Ruchika Singhal | Medtronic | Business Development |
| Elliot Krames | Pacific Pain Treatment Center | Clinical, Patient Advocacy |
| Kam Leong | Columbia Univ. | Scientist, Technology |
| Paul Sadja | Columbia Univ. | Scientist, Technology |
| Bin He | Director, U Minn | Scientist, Technology |
| Krishna Shenoy | Stanford | Scientist, Technology |
| Doug Weber | Pittsburgh | Scientist, Technology |
| Howard Riina | NYU Langone Health | Clinical , Scientist |